 |
|
Subscribe to the MGSD.org newsletter to get more informations.
|  |
|
 |
 |
 |
Epidemiology
|
|
|
|
|
1 month |
3 months |
All |
|
|
|
|
|
|
|
|
| Genetics (Type 1) |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
| Genetics (Type 2) |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
| Prediction, prevention of type 1 diabetes |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
| Prediction, prevention of type 2 diabetes |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
| Public health, cost of care, pharmacoeconomy |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
| Screening |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
|
Clinical setting
|
|
|
|
|
1 month |
3 months |
All |
|
|
|
|
|
|
|
|
| Acute complications of diabetes |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
| Depression |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
| Diabetes in childhood (Type 1) |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
| Diabetes in childhood (Type 2) |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
| Diabetic foot |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
| Diabetes in elderly |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
| Gestational diabetes |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
| Hypoglycemia |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
| LADA, slow type 1 in adults |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
| Mitochondrial diabetes |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
| MODY, Maturity onset type of diabetes in the young |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
| Secondary diabetes (endocrinology, pancreatic disease, etc) |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
| Sleep apnea |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
|
Risk factors
Complications
|
|
|
|
|
1 month |
3 months |
All |
|
|
|
|
|
|
|
|
| Coronary heart disease |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
| End stage renal failure |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
| Heart failure |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
| Lower limb artery disease |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
| Nephropathy in type 1 diabetes |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
| Nephropathy in type 2 diabetes |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
| Neuropathy, autonomic, including sexual dysfunction |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
| Neuropathy, peripheral |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
| Non alcoholic steatohepatitis (NASH) |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
| Oral and dental complications |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
| Osteoporosis |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
| Retinopathy |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
| Stroke |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
|
Pathophysiology
|
|
|
|
|
1 month |
3 months |
All |
|
|
|
|
|
|
|
|
| Adipocytokines |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
| Endothelial dysfunction |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
| Glucagon |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
| Glucose metabolism |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
| Immunology in type 1 diabetes |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
| Insulin action |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
| Insulin secretion |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
| Insulin signaling cascade, signal transduction |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
| Islet of Langerhans, Beta cell |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
|
Treatment
|
|
|
|
|
1 month |
3 months |
All |
|
|
|
|
|
|
|
|
| Education, empowerment |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
| Genomic therapy |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
| Insulin therapy |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
| Nutrition |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
| Oral antidiabetic agents |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
| Pancreas or islet transplantations |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
| Physical exercise |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
| Recommendations or guidelines |
Go |
Go |
Go |
|
|
|
|
|
|
|
|
|
|
This web site is the property of MGSD © 2008 Mediterranean Group for the Study of Diabetes - All rights reserved.
|